Britannia Life Sciences Inc. (BLSIF)

OTCMKTS · Delayed Price · Currency is USD
0.0600
+0.0300 (100.00%)
At close: Feb 23, 2026
Market Cap10.55M +49.1%
Revenue (ttm)115.00K -28.5%
Net Income14.94M
EPS0.09
Shares Outn/a
PE Ratio0.71
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume5,004
Average Volume5,378
Open0.0600
Previous Close0.0300
Day's Range0.0600 - 0.0600
52-Week Range0.0300 - 0.0780
Beta-0.16
RSIn/a
Earnings DateJul 30, 2026

About Britannia Life Sciences

Britannia Life Sciences Inc. engages in the product testing, safety assessment, and manufacturing services in the United Kingdom and internationally. It serves cosmetics, consumer packaged and household goods, and nutraceutical industries. The company is headquartered in Toronto, Canada. [Read more]

Industry Biotechnology
Sector Healthcare
CEO Peter Shippen
Country Canada
Stock Exchange OTCMKTS
Ticker Symbol BLSIF

Financial Performance

Financial numbers in CAD Financial Statements